TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Octapharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
215,338
|
187,359
|
174,842 |
Financial expenses |
11
|
1,074
|
606 |
Earnings before taxes |
16,262
|
7,583
|
7,486 |
EBITDA |
34,447
|
28,044
|
31,354 |
Total assets |
164,751
|
126,621
|
174,628 |
Current assets |
59,900
|
39,986
|
73,824 |
Current liabilities |
34,196
|
32,278
|
26,416 |
Equity capital |
104,792
|
91,711
|
93,185 |
- share capital |
2,253
|
2,247
|
2,445 |
Employees (average) |
1,065
|
984
|
882 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.6%
|
72.4%
|
53.4% |
Turnover per employee |
202
|
190
|
198 |
Profit as a percentage of turnover |
7.6%
|
4.0%
|
4.3% |
Return on assets (ROA) |
9.9%
|
6.8%
|
4.6% |
Current ratio |
175.2%
|
123.9%
|
279.5% |
Return on equity (ROE) |
15.5%
|
8.3%
|
8.0% |
Change turnover |
27,434
|
26,679
|
-9,597 |
Change turnover % |
15%
|
17%
|
-5% |
Chg. No. of employees |
81
|
102
|
-6 |
Chg. No. of employees % |
8%
|
12%
|
-1% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.